Happy To Have Sold 'Value Trap' Amgen [View article]
Dear Mike Goodson, I commend you for stating what you did and to make a new stance although you loved the stock. It's not easy when you own a company like amgn and feel your in the right stock with all its potential besides. As you said it was a value trap and just looking at that 5 year chart I can fully understand. Which brings me to 'nstk' with a similar chart for 5 years(about the same value consistently), except this is not a stock of the same level. But when recent statements that nastech has potential in three areas being, Autism, Obesity, and Rnai, it raised a red flag to me. I found other companies way ahead of 'nstk' in all three areas, so maybe it's more Hype than reality. There ahead by years and later phases too. nstk is in the early stages so they are probably 5-15 years away, which makes me wonder as a shareholder that maybe this is a 'Value Trap' too. What's your perspective Mike, Jimmy T
-
Dear Mike Goodson, I commend you for stating what you did and to make a new stance although you loved the stock. It's not easy when you own a company like amgn and feel your in the right stock with all its potential
Aug 21 10:22 am
|Rating:
0
0
All Comments by jimmy Turano »Happy To Have Sold 'Value Trap' Amgen [View article]
besides. As you said it was a value trap and just looking at that 5 year chart I can fully understand.
Which brings me to 'nstk' with a similar chart for 5 years(about the same value consistently), except this is not a stock of the same level. But when recent statements that nastech has potential in three areas being, Autism, Obesity, and Rnai, it raised a red flag to me. I found other companies way ahead of 'nstk' in all three areas, so
maybe it's more Hype than reality. There ahead by years and later phases too. nstk is in the early stages so they are probably 5-15 years away, which makes me wonder as a shareholder that maybe this is a 'Value Trap' too.
What's your perspective Mike,
Jimmy T